The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Moretti August J since 2006.
This trader's CIK number is 1344412.
At the time of last reporting, Moretti August J was the Chief Financial Officer of 4d Molecular Therapeutics, Inc.. (stock ticker symbol FMDT).
Also see all insider trading activities at 4d Molecular Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | FMDT | 0 | $0 | 0 | $0 | 3,000 | $28,230 |
| 2022 | FMDT | 0 | $0 | 0 | $0 | 3,000 | $28,230 |
| 2021 | FMDT | 0 | $0 | 0 | $0 | 1,000 | $9,410 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2010 | ALXA | 0 | $0 | 10,000 | $35,000 | 10,000 | $13,799 |
| 2009 | ALXA | 0 | $0 | 14,009 | $31,219 | 0 | $0 |
| 2008 | ALXA | 0 | $0 | 10,000 | $75,485 | 10,000 | $13,798 |
| 2007 | ALXA | 0 | $0 | 10,000 | $86,270 | 10,000 | $13,798 |
| 2006 | ALXA | 0 | $0 | 2,000 | $16,600 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2016 | DEPO | 0 | $0 | 15,000 | $301,200 | 8,297 | $105,288 |
| 2015 | DEPO | 0 | $0 | 15,000 | $270,975 | 5,000 | $26,750 |
| 2014 | DEPO | 0 | $0 | 5,339 | $84,639 | 0 | $0 |
| 2013 | DEPO | 0 | $0 | 2,821 | $23,707 | 2,500 | $13,375 |
1. 4d Molecular Therapeutics, Inc. (FMDT)
2. Alexza Pharmaceuticals Inc. (ALXA)
3. Assertio Therapeutics, Inc (DEPO)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-05-15 | FMDT | Option Ex | 3,000 | 9.41 | 28,230 |
| 2022-12-21 | FDMT | Option Ex | 3,000 | 9.41 | 28,230 |
| 2021-04-12 | FDMT | Option Ex | 1,000 | 9.41 | 9,410 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2010-05-05 | ALXA | Option Ex | 10,000 | 1.38 | 13,799 |
| 2010-05-05 | ALXA | Sale | 10,000 | 3.50 | 35,000 |
| 2009-12-16 | ALXA | Sale | 4,435 | 2.41 | 10,675 |
| 2009-12-17 | ALXA | Sale | 2,457 | 2.20 | 5,407 |
| 2009-12-18 | ALXA | Sale | 7,117 | 2.13 | 15,137 |
| 2008-04-01 | ALXA | Option Ex | 5,000 | 1.38 | 6,899 |
| 2008-04-01 | ALXA | Sale | 5,000 | 7.17 | 35,835 |
| 2008-01-02 | ALXA | Sale | 5,000 | 7.93 | 39,650 |
| 2008-01-02 | ALXA | Option Ex | 5,000 | 1.38 | 6,899 |
| 2007-10-01 | ALXA | Option Ex | 5,000 | 1.38 | 6,899 |
| 2007-10-01 | ALXA | Sale | 5,000 | 8.59 | 42,970 |
| 2007-08-01 | ALXA | Sale | 5,000 | 8.66 | 43,300 |
| 2007-08-01 | ALXA | Option Ex | 5,000 | 1.38 | 6,899 |
| 2006-12-07 | ALXA | Sale | 2,000 | 8.30 | 16,600 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2016-11-14 | DEPO | Option Ex | 5,000 | 12.69 | 63,450 |
| 2016-11-14 | DEPO | Sale | 5,000 | 20.84 | 104,200 |
| 2016-08-10 | DEPO | Sale | 5,000 | 21.40 | 107,000 |
| 2016-08-10 | DEPO | Option Ex | 3,297 | 12.69 | 41,838 |
| 2016-05-09 | DEPO | Sale | 5,000 | 18.00 | 90,000 |
| 2015-12-16 | DEPO | Option Ex | 5,000 | 5.35 | 26,750 |
| 2015-12-03 | DEPO | Sale | 15,000 | 18.07 | 270,975 |
| 2014-12-02 | DEPO | Sale | 5,339 | 15.85 | 84,639 |
| 2013-12-02 | DEPO | Sale | 2,821 | 8.40 | 23,707 |
| 2013-05-17 | DEPO | Option Ex | 2,500 | 5.35 | 13,375 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Moretti August J (Chief Financial Officer of 4d Molecular Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.